SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008072
Filing Date
2024-05-14
Accepted
2024-05-14 09:00:46
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q capr-20240331x10q.htm   iXBRL 10-Q 1256917
2 EX-31.1 capr-20240331xex31d1.htm EX-31.1 10571
3 EX-31.2 capr-20240331xex31d2.htm EX-31.2 10306
4 EX-32.1 capr-20240331xex32d1.htm EX-32.1 5833
5 EX-32.2 capr-20240331xex32d2.htm EX-32.2 5821
  Complete submission text file 0001558370-24-008072.txt   5568869

Data Files

Seq Description Document Type Size
6 EX-101.SCH capr-20240331.xsd EX-101.SCH 46726
7 EX-101.CAL capr-20240331_cal.xml EX-101.CAL 35681
8 EX-101.DEF capr-20240331_def.xml EX-101.DEF 201162
9 EX-101.LAB capr-20240331_lab.xml EX-101.LAB 352348
10 EX-101.PRE capr-20240331_pre.xml EX-101.PRE 295696
61 EXTRACTED XBRL INSTANCE DOCUMENT capr-20240331x10q_htm.xml XML 780907
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34058 | Film No.: 24941634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)